This template captures CRISPR/Cas9 RNP-mediated editing of the BCL11A erythroid enhancer in HEK293T cells, a well-validated target for proof-of-concept editing experiments and HbF reactivation research.
Goal: achieve ≥60% editing efficiency at the BCL11A +58 GATA1 binding site in HEK293T cells via Cas9 RNP electroporation, with verification by T7E1 mismatch assay and ICE-Sanger indel deconvolution.
Method overview: Synthetic sgRNA (Synthego or IDT, 100 nmol scale, 5′-modified for stability) targeting BCL11A +58 enhancer is complexed with 5 µg recombinant SpCas9 protein (Aldevron or IDT HiFi v3) at room temperature for 20 minutes in PBS. 200,000 HEK293T cells per condition are nucleofected using Lonza 4D-Nucleofector SF reagent (program CM-130). Cells are plated in 24-well format, harvested at 72 hours post-nucleofection. Genomic DNA extracted (Qiagen DNeasy), 500 bp amplicon spanning the cut site PCR-amplified, T7E1 cleavage assay run on agarose, and amplicon Sanger-sequenced for ICE analysis.
Expected: 60-75% editing efficiency in the bulk population (T7E1 cleavage 30-45% scaled to ICE). Indel spectrum dominated by +1 insertion, −1 deletion, and small (1-7 bp) deletions. Single-cell clones (4-6 picked) typically yield 50-70% homozygous knockout. No off-target effects at top-3 predicted sites by GUIDE-seq.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Indel | Frequency (%) | Reads | Notes |
| 2 | WT (no edit) | 35 | 352 | unedited allele |
| 3 | +1 ins (A) | 22 | 218 | most frequent edit |
| 4 | -1 del (T) | 18 | 181 | second most frequent |
| 5 | -2 del | 10 | 101 | |
| 6 | -5 del | 8 | 79 | in-frame disruption |
| 7 | -7 del | 4 | 42 | |
| 8 | other | 3 | 27 | larger indels / complex |
Use Ctrl + click to add text
{
"experiment": {
"id": 314,
"custom_id": "CR-BCL11A-2026-019",
"title": "CRISPR edit: BCL11A enhancer / HEK293T / Cas9 RNP",
"template": "CRISPR Cas9 Editing",
"template_version": "v3.2",
"category": "Molecular Biology",
"status": "Complete",
"started_on": "2026-07-20",
"tags": [
"CRISPR",
"Cas9-RNP",
"BCL11A",
"gene-editing",
"sgRNA"
]
},
"main_text": "This template captures CRISPR/Cas9 RNP-mediated editing of the BCL11A erythroid enhancer in HEK293T cells, a well-validated target for proof-of-concept editing experiments and HbF reactivation research.\nGoal: achieve ≥60% editing efficiency at the BCL11A +58 GATA1 binding site in HEK293T cells via Cas9 RNP electroporation, with verification by T7E1 mismatch assay and ICE-Sanger indel deconvolution.\nMethod overview: Synthetic sgRNA (Synthego or IDT, 100 nmol scale, 5′-modified for stability) targeting BCL11A +58 enhancer is complexed with 5 µg recombinant SpCas9 protein (Aldevron or IDT HiFi v3) at room temperature for 20 minutes in PBS. 200,000 HEK293T cells per condition are nucleofected using Lonza 4D-Nucleofector SF reagent (program CM-130). Cells are plated in 24-well format, harvested at 72 hours post-nucleofection. Genomic DNA extracted (Qiagen DNeasy), 500 bp amplicon spanning the cut site PCR-amplified, T7E1 cleavage assay run on agarose, and amplicon Sanger-sequenced for ICE analysis.\nExpected: 60-75% editing efficiency in the bulk population (T7E1 cleavage 30-45% scaled to ICE). Indel spectrum dominated by +1 insertion, −1 deletion, and small (1-7 bp) deletions. Single-cell clones (4-6 picked) typically yield 50-70% homozygous knockout. No off-target effects at top-3 predicted sites by GUIDE-seq.",
"extra_fields": {
"Target": {
"Target gene": {
"type": "text",
"value": "BCL11A (+58 erythroid enhancer)"
},
"sgRNA name": {
"type": "text",
"value": "sg-BCL11A-58-3"
},
"sgRNA sequence": {
"type": "text",
"value": "CTAACAGTTGCTTTTATCAC 20 nt"
},
"PAM": {
"type": "text",
"value": "AGG"
}
},
"Guide & Delivery": {
"Cell line": {
"type": "select",
"value": "HEK293T, K562, U2OS, iPSC, primary T"
},
"Delivery method": {
"type": "select",
"value": "electroporation, lipofection, viral transduction"
},
"Cas9 source": {
"type": "select",
"value": "SpCas9 WT, HiFi Cas9, dCas9, BE3, BE4-max, PE2"
},
"EP program": {
"type": "text",
"value": "Lonza 4D-Nucleofector · SF · CM-130"
}
},
"Verification": {
"Editing efficiency": {
"type": "number",
"value": "65 % (ICE)"
},
"T7E1 cleavage": {
"type": "number",
"value": "38 %"
},
"Dominant indel": {
"type": "text",
"value": "+1 insertion (22%) · -1 deletion (18%)"
},
"Clones genotyped": {
"type": "text",
"value": "4 / 6 homozygous KO"
}
}
},
"attached_files": [
{
"filename": "sgRNA_design.pdf",
"type": "pdf",
"size": "292 KB"
},
{
"filename": "T7E1_gel.tif",
"type": "png",
"size": "2.1 MB"
},
{
"filename": "sanger_ICE_traces.zip",
"type": "docx",
"size": "4.8 MB"
}
],
"steps": [
{
"n": 1,
"description": "Design sgRNA targeting BCL11A +58 enhancer using CRISPick + manual off-target check",
"duration": "0:45",
"complete": true,
"note": "Top score; 0 off-targets with ≤2 mismatches in coding"
},
{
"n": 2,
"description": "Order synthetic sgRNA (Synthego, 100 nmol, 5' chemically modified)",
"duration": "0:05",
"complete": true,
"note": "Lot CR2026-014 received 2026-06-01"
},
{
"n": 3,
"description": "Resuspend sgRNA to 100 µM in nuclease-free TE, aliquot 10 µL × -80 °C",
"duration": "0:10",
"complete": true
},
{
"n": 4,
"description": "Pre-complex: 5 µg Cas9 + 100 pmol sgRNA in 5 µL PBS, RT 20 min",
"duration": "0:22",
"complete": true
},
{
"n": 5,
"description": "Trypsinize HEK293T, count, resuspend 2×10⁵ cells/condition in 20 µL SF reagent",
"duration": "0:20",
"complete": true
},
{
"n": 6,
"description": "Mix cells + RNP, nucleofect Lonza 4D-Nucleofector program CM-130",
"duration": "0:10",
"complete": true,
"note": "Run 06:04:11:42"
},
{
"n": 7,
"description": "Plate cells in 24-well + pre-warmed DMEM/10% FBS, return to 37°C incubator",
"duration": "0:08",
"complete": true
},
{
"n": 8,
"description": "Harvest cells at 72 h, extract gDNA (Qiagen DNeasy), elute 50 µL",
"duration": "1:30",
"complete": true,
"note": "Concentration 142 ng/µL · A₂₆₀/A₂₈₀ 1.92"
},
{
"n": 9,
"description": "PCR amplify 500 bp locus across cut site; run T7E1 mismatch on portion",
"duration": "2:30",
"complete": true,
"note": "T7E1 38% cleavage"
},
{
"n": 10,
"description": "Sanger sequence amplicon (Eurofins), upload to ICE for indel deconvolution",
"duration": "24:00",
"complete": true,
"note": "ICE 65% efficiency · KO score 0.61"
}
],
"spreadsheet": [
[
"Indel",
"Frequency (%)",
"Reads",
"Notes"
],
[
"WT (no edit)",
"35",
"352",
"unedited allele"
],
[
"+1 ins (A)",
"22",
"218",
"most frequent edit"
],
[
"-1 del (T)",
"18",
"181",
"second most frequent"
],
[
"-2 del",
"10",
"101",
""
],
[
"-5 del",
"8",
"79",
"in-frame disruption"
],
[
"-7 del",
"4",
"42",
""
],
[
"other",
"3",
"27",
"larger indels / complex"
]
],
"links": {
"experiments": [
{
"ref_id": "EXP-2026-0521",
"title": "sgRNA design + off-target screen (CRISPick)",
"owner": "S. Khan",
"date": "May 21"
},
{
"ref_id": "EXP-2026-0608",
"title": "Single-cell clone picking + genotype",
"owner": "S. Khan",
"date": "Jun 8"
}
],
"resources": [
{
"ref_id": "SOP-0412",
"title": "CRISPR Cas9 RNP SOP v2.0",
"owner": "QA Team",
"date": "Apr 12"
},
{
"ref_id": "IBC-2026",
"title": "IBC approval — BCL11A editing protocol",
"owner": "Biosafety Office",
"date": "Mar 14"
},
{
"ref_id": "TOOL-ICE",
"title": "Synthego ICE Sanger deconvolution tool",
"owner": "External Tools",
"date": "Jan 28"
}
]
},
"compounds": [
{
"name": "SpCas9 protein (Aldevron, 10 µg/µL)",
"catalog_lot": "#9212-0250 · Lot 2562194",
"stock_status": "In stock"
},
{
"name": "sg-BCL11A-58-3 synthetic sgRNA (100 nmol)",
"catalog_lot": "Synthego CR2026-014",
"stock_status": "In stock"
},
{
"name": "SF Cell Line Nucleofector kit",
"catalog_lot": "V4XC-2024 · Lot 3621842",
"stock_status": "In stock"
},
{
"name": "T7 Endonuclease I (T7E1)",
"catalog_lot": "M0302S · Lot 10174612",
"stock_status": "In stock"
},
{
"name": "Q5 High-Fidelity 2× Master Mix",
"catalog_lot": "M0492 · Lot 10174924",
"stock_status": "In stock"
},
{
"name": "Qiagen DNeasy Blood & Tissue Kit",
"catalog_lot": "69504 · Lot 172421842",
"stock_status": "Low"
}
],
"storage": [
{
"name": "Cas9 protein aliquots (5 µg working)",
"location": "-80 °C · Freezer A-3 · Drawer 4 · Box CR-CAS9-2026",
"count": "×8"
},
{
"name": "sgRNA stock + working dilutions",
"location": "-80 °C · Freezer A-3 · Drawer 4 · Box CR-SG-2026",
"count": "×6"
},
{
"name": "Edited cell clones (frozen working stocks)",
"location": "-80 °C · Freezer A-2 · Rack 6 · Box BCL11A-CLO",
"count": "×4"
}
],
"permissions": {
"visibility": [
{
"type": "Team",
"name": "Khan Lab"
},
{
"type": "Person",
"name": "S. Khan"
}
],
"can_write": [
{
"type": "Person",
"name": "S. Khan"
},
{
"type": "Person",
"name": "Dr. P. Joshi"
}
]
}
}